A challenge to the therapeutic nihilism of ESPAC-1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A challenge to the therapeutic nihilism of ESPAC-1

Published:2005-03 Issue:4 Volume:61 Page:965-966
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Koshy Mary C.,Landry Jerome C.,Cavanaugh Sean X.,Fuller Clifton D.,Willett Christopher G.,Abrams Ross A.,Hoffman John P.,Thomas Charles R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference10 articles.

1. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

2. Adjuvant therapy for pancreatic cancer—the debate continues;Choti;N Engl J Med,2004

3. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group;Moertel;Cancer,1981

4. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone;J Natl Cancer Inst,1988

5. Pancreatic cancer;Kalser;Arch Surg,1985

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy;Annals of Surgical Oncology;2024-05-24

2. Krüppel-like Factor 10 as a Prognostic and Predictive Biomarker of Radiotherapy in Pancreatic Adenocarcinoma;Cancers;2023-10-30

3. Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy;Radiation Oncology;2023-08-18

4. Neoadjuvant chemotherapy for resectable pancreatic cancer: a new standard of care?;Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery;2023-03-19

5. Quality control;Translational Radiation Oncology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3